Inventor · disambiguated record
Marja H. Jaattela
Also filed as: JAATTELA MARJA · JAATTELA MARJA H · JAATTELA MARJA HELENA
7 granted patents·4 pending applications·34 citations·filing 2002–2022
86Inventor score
Top patents by PatentIndex Score
11 records- 0191US11045460B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Jun 29, 2021·4 cites·5 claims
- 0290US11304941B2Use of HSP70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Apr 19, 2022·3 cites·5 claims
- 0389US10543204B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2017·Granted Jan 28, 2020·6 cites·14 claims
- 0487US11938125B2Use of Hsp70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2022·Granted Mar 26, 2024·1 cites·5 claims
- 0587US9884058B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2016·Granted Feb 6, 2018·8 cites·13 claims
- 0686US9289472B2Use of HSP70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2013·Granted Mar 22, 2016·10 cites·14 claims
- 0777US8540985B2Use of Hsp70 as a regulator of enzymatic activityJENSEN THOMAS KIRKEGAARD·Filed 2009·Granted Sep 24, 2013·2 cites·11 claims
- 0865US2009203721A1Use of siramesine in the treatment of cancerLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 0961US2015004151A1Use of hsp70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2014·Application pending·0 cites
- 1053US2006178389A1Use of siramesine in the treatment of cancerTHOMSEN CHRISTIAN·Filed 2005·Application pending·0 cites
- 1137US2004077634A1Treatment of diseases characterized by excessive or insufficient cell deathFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marja H. Jaattela files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →